UPDATE: Cantor Ftizgerald Raises LifePoint Hospitals PT; Reiterates Buy Rating

According to a research report this morning, Cantor Fitzgerald raises its PT for LifePoint Hospitals LPNT from $44 to $46 to reflect a strong first quarter as they reiterate a Buy rating. Cantor Fitzgerald stated, “Key basic measures of demand improved substantially in 1Q:12, including adjusted admissions, which were essentially flat (down 0.4%), but better than the past 18 months; surgery, which jumped 4.9%; and ER visits, which increased 1.6%. Revenue per admission, a measure of mix, jumped 4.7% (before a Medicare settlement), one of the best results that LifePoint has posted in this metric over the past two years.” LifePoint Hospitals closed Friday at $39.94.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorReiterationAnalyst RatingsCantor FitzgeraldHealth CareHealth Care Facilities
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!